Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,919.50p

Change Today:

14.00p
52 Week High: 2,208.00
52 Week Low: 1,373.00

Currency: UK Pounds
Shares Issued: 4,045.40m
Volume: 5,843,229

Market Cap: £77,651m
RiskGrade: 129
Beta: 0.00

Trade now with Barclays Stockbrokers

Update - GSK's interim report is due soon - find out more Find out more

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

1 Day Chart

6 Month Chart

More GSK charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	3.3%	0.0%
Div Cover	2.6	2.5
Op Mrgn	24.3%	28.9%
ROCE	62.0%

	Latest	F'cast
P/E	11.5	12.1
PEG	1.4	2.2
Pr/Revenue	2.5	2.6
Pr/Book	5.0

	Latest	F'cast
Revenue	4.1%	-100.0%
PBT	112.9%	-100.0%
EPS	8.0%	3.8%
DPS	8.2%	n/a

GSK Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-21	24,696.00	3,599.00	90.56p	22.2	n/a	-22%	80.00p	4.0%
31-Dec-22	29,324.00	5,628.00	139.70p	10.3	0.2	+54%	44.00p	3.1%
31-Dec-23	30,328.00	6,064.00	155.10p	9.4	0.9	+11%	58.00p	4.0%
31-Dec-24	31,376.00	3,477.00	159.30p	8.5	2.8	+3%	61.00p	4.5%
31-Dec-25	32,667.00	7,401.00	172.00p	10.6	1.3	+8%	66.00p	3.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Company Announcements

Director/PDMR Shareholding	24-Jul-2026	15:30	RNS
Admission to Trading	24-Jul-2026	15:00	RNS
Jideytro approved in US for certain lung cancers	22-Jul-2026	17:22	RNS

More gsk company announcements

GSK ShareCast News

GSK secures EMA review for single‑dose Bex...	20-Jul-2026	ShareCast
GSK shares fall as cough drug development axed	17-Jul-2026	ShareCast
GSK rectal cancer drug shows positive result in ...	13-Jul-2026	ShareCast

More GSK ShareCast news

GSK Top Newspaper Links

GSK to buy US cancer treatment firm Nuvalent for...	09-Jun-2026	Guardian
GSK signs £45m deal with UCL offshoot for liver ...	08-Jun-2026	Times
Strong vaccine sales deliver an early boost for ...	29-Apr-2026	Times

Latest GSK Director Deals

Traded	Action	Notifier	Price	Amount	Value
10-Jul-26	Buy Dividends	Vishal Sikka	1,968.32p	218	£4,290.94
10-Jul-26	Buy Dividends	Jeannie Lee	1,968.32p	34	£669.23
10-Jul-26	Buy Dividends	Harry (Hal) C. Dietz	1,968.32p	70	£1,377.83

More GSK director deals

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

GSK Market Data

Currency	UK Pounds
Share Price	1,919.50p
Change Today	14.00p
% Change	0.73 %
52 Week High	2,208.00
52 Week Low	1,373.00
Volume	5,843,229
Shares Issued	4,045.40m
Market Cap	£77,651m
Beta	0.00
RiskGrade	129